GBS Inc. - GBS

SEC FilingsOur GBS Tweets

About Gravity Analytica

Recent News

  • 06.04.2025 - How to Choose the Right Drug Test for Your Work
  • 05.28.2025 - Random Drug Testing at Work: A Simpler Way to Stay Compliant
  • 05.22.2025 - Intelligent Bio Solutions to Showcase Fingerprint Drug Testing at RISE25 Conference from May 28-31, Supporting Innovation in U.S. Forensic Drug Testing
  • 05.19.2025 - Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Testing Capabilities in Remote Queensland Workforce Deployment
  • 05.13.2025 - Intelligent Bio Solutions Announces Fiscal Q3 2025 Financial Results and Key Operational Achievements
  • 05.06.2025 - Intelligent Bio Solutions Drives Global Growth Through Multilingual Digital Expansion
  • 04.22.2025 - Intelligent Bio Solutions Expands Global Reach with Latin American Spanish Language Integration into Drug Screening System
  • 04.16.2025 - The History of Fingerprint Drug Testing
  • 03.31.2025 - Intelligent Bio Solutions Expands Middle East Market Reach with Arabic Integration in Drug Screening System

Recent Filings

  • 05.30.2025 - S-8 Securities to be offered to employees in employee benefit plans
  • 05.16.2025 - 8-K Current report
  • 05.13.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 05.13.2025 - 8-K Current report
  • 05.13.2025 - EX-99.1 EX-99.1
  • 04.29.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
  • 04.28.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
  • 04.11.2025 - S-3 Registration statement under Securities Act of 1933
  • 04.01.2025 - DEF 14A Other definitive proxy statements
  • 04.01.2025 - ARS Annual Report to Security Holders